Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - May 1 2022

Publication series

NameArticles, Abstracts, and Reports

Cite this